Animal tissue injury studies
BPC-157
Animal studies explore how muscles, tendons, and the lining of the digestive tract heal after injury and what role BPC-157 might play.
Investigational research
Emerging science. Personalized medicine.
Annos Wellness is developing a personalized peptide therapy program, bringing together emerging research, individualized clinical evaluation, and thoughtful medical oversight.
Treatment options will be determined by clinical appropriateness, applicable regulations, and lawful pharmacy availability.
Discover six peptides under investigation in tissue repair, metabolism, inflammation, aging biology, and neurological function.
These peptides are investigational and not FDA-approved. Human evidence is limited, and long-term risks remain uncertain.
The peptides featured are investigational and have not received FDA approval. Research into their potential benefits, safety, and effectiveness is ongoing. Annos Wellness plans to offer individualized peptide therapy, subject to clinical evaluation, applicable regulations, and appropriate pharmacy sourcing.
Human evidence is limited, and long-term risks remain uncertain. Annos has not confirmed a pharmacy source for these options.
Enrollment is currently closed. Future coverage and lawful availability have not been established.